Biostage Financial Statements From 2010 to 2024
| BSTGDelisted Stock | USD 4.20 0.09 2.10% |
Check Biostage financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biostage's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biostage financial statements analysis is a perfect complement when working with Biostage Valuation or Volatility modules.
Biostage |
Biostage OTC Stock Shares Outstanding Analysis
Biostage's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Biostage Shares Outstanding | 11.64 M |
Most of Biostage's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biostage is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Biostage has 11.64 M of shares currently outstending. This is 93.55% lower than that of the Biotechnology sector and 89.1% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 97.96% higher than that of the company.
Biostage Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biostage's current stock value. Our valuation model uses many indicators to compare Biostage value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biostage competition to find correlations between indicators driving Biostage's intrinsic value. More Info.Biostage is rated second in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biostage's earnings, one of the primary drivers of an investment's value.About Biostage Financial Statements
Biostage stakeholders use historical fundamental indicators, such as Biostage's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biostage investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biostage's assets and liabilities are reflected in the revenues and expenses on Biostage's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biostage. Please read more on our technical analysis and fundamental analysis pages.
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts. Biostage operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Biostage OTC Stock
If you are still planning to invest in Biostage check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostage's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |